These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33116835)

  • 1. Evaluation of Serum Exosomal lncRNAs as Diagnostic and Prognostic Biomarkers for Esophageal Squamous Cell Carcinoma.
    Yan S; Du L; Jiang X; Duan W; Li J; Xie Y; Zhan Y; Zhang S; Wang L; Li S; Wang C
    Cancer Manag Res; 2020; 12():9753-9763. PubMed ID: 33116835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A RASSF8-AS1 based exosomal lncRNAs panel used for diagnostic and prognostic biomarkers for esophageal squamous cell carcinoma.
    Xie K; Zheng C; Gu W; Jiang Z; Luo C; Luo J; Diao Y; Wang G; Cong Z; Yao X; Hu L; Shen Y
    Thorac Cancer; 2022 Dec; 13(23):3341-3352. PubMed ID: 36266257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma.
    Tong YS; Wang XW; Zhou XL; Liu ZH; Yang TX; Shi WH; Xie HW; Lv J; Wu QQ; Cao XF
    Mol Cancer; 2015 Jan; 14():3. PubMed ID: 25608466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
    Li W; Liu J; Zhao H
    Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-Secreted Exosomal lncRNA POU3F3 Promotes Cisplatin Resistance in ESCC by Inducing Fibroblast Differentiation into CAFs.
    Tong Y; Yang L; Yu C; Zhu W; Zhou X; Xiong Y; Wang W; Ji F; He D; Cao X
    Mol Ther Oncolytics; 2020 Sep; 18():1-13. PubMed ID: 32637576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of serum exosomal LncRNA-based biomarker panel for diagnosis and recurrence prediction of bladder cancer.
    Zhang S; Du L; Wang L; Jiang X; Zhan Y; Li J; Yan K; Duan W; Zhao Y; Wang L; Wang Y; Shi Y; Wang C
    J Cell Mol Med; 2019 Feb; 23(2):1396-1405. PubMed ID: 30467945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of a seven-lncRNA signature in patients with esophageal squamous cell carcinoma: a lncRNA expression analysis.
    Weng NQ; Chi J; Wen J; Mai SJ; Zhang MY; Huang L; Liu J; Yang XZ; Xu GL; Fu JH; Wang HY
    J Transl Med; 2020 Jan; 18(1):47. PubMed ID: 32005248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA sequencing of exosomes revealed differentially expressed long noncoding RNAs in early-stage esophageal squamous cell carcinoma and benign esophagitis.
    Tian L; Yang L; Zheng W; Hu Y; Ding P; Wang Z; Zheng D; Fu L; Chen B; Xiao T; Wang Y; Chen F; Liu J; Gao K; Shen S; Zhai R
    Epigenomics; 2020 Mar; 12(6):525-541. PubMed ID: 32043367
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
    Zhan Y; Du L; Wang L; Jiang X; Zhang S; Li J; Yan K; Duan W; Zhao Y; Wang L; Wang Y; Wang C
    Mol Cancer; 2018 Sep; 17(1):142. PubMed ID: 30268126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein-coding genes combined with long non-coding RNAs predict prognosis in esophageal squamous cell carcinoma patients as a novel clinical multi-dimensional signature.
    Guo JC; Li CQ; Wang QY; Zhao JM; Ding JY; Li EM; Xu LY
    Mol Biosyst; 2016 Oct; 12(11):3467-3477. PubMed ID: 27714034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of Serum Exosomal LncRNA TBILA and AGAP2-AS1 as Promising Biomarkers for Diagnosis of Non-Small Cell Lung Cancer.
    Tao Y; Tang Y; Yang Z; Wu F; Wang L; Yang L; Lei L; Jing Y; Jiang X; Jin H; Bai Y; Zhang L
    Int J Biol Sci; 2020; 16(3):471-482. PubMed ID: 32015683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma.
    Yu J; Wu X; Huang K; Zhu M; Zhang X; Zhang Y; Chen S; Xu X; Zhang Q
    Mol Med Rep; 2019 Jun; 19(6):5309-5320. PubMed ID: 31059058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum exosomal long non-coding RNA SNHG15 expression predicts poor prognosis in non-small cell lung cancer.
    Han P; Zhao J; Gao L
    J Clin Lab Anal; 2021 Nov; 35(11):e23979. PubMed ID: 34551140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal LncRNA RP5-977B1 as a novel minimally invasive biomarker for diagnosis and prognosis in non-small cell lung cancer.
    Min L; Zhu T; Lv B; An T; Zhang Q; Shang Y; Yu Z; Zheng L; Wang Q
    Int J Clin Oncol; 2022 Jun; 27(6):1013-1024. PubMed ID: 35482171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulated expression of serum exosomal hsa_circ_0026611 is associated with lymph node metastasis and poor prognosis of esophageal squamous cell carcinoma.
    Liu S; Lin Z; Rao W; Zheng J; Xie Q; Lin Y; Lin X; Chen H; Chen Y; Hu Z
    J Cancer; 2021; 12(3):918-926. PubMed ID: 33403048
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum exosomal miR-182 upregulation predicts unfavorable prognosis of esophageal squamous cell carcinoma.
    Qiu ML; Li X; Lin JB; Luo RG; Liu B; Feng Z
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5412-5418. PubMed ID: 32495876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA Profiles Enable Prognosis Prediction and Subtyping for Esophageal Squamous Cell Carcinoma.
    Zhang S; Li J; Gao H; Tong Y; Li P; Wang Y; Du L; Wang C
    Front Cell Dev Biol; 2021; 9():656554. PubMed ID: 34127945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Long Non-Coding RNAs LINC00324 and LOC100507053 as Potential Liquid Biopsy Markers for Esophageal Squamous Cell Carcinoma: A Pilot Study.
    Sharma U; Barwal TS; Khandelwal A; Rana MK; Rana APS; Singh K; Jain A
    Front Oncol; 2022; 12():823953. PubMed ID: 35237522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
    Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY
    BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-lncRNA signature in plasma exosomes serves as diagnostic biomarker for esophageal squamous cell carcinoma.
    Jiao Z; Yu A; Rong W; He X; Zen K; Shi M; Wang T
    Aging (Albany NY); 2020 Jun; 12(14):15002-15010. PubMed ID: 32597791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.